TY  - GEN
AU  - Pérez-Belmonte, Luis M.
AU  - Ricci, Michele
AU  - Sanz-Cánovas, Jaime
AU  - Millán-Gómez, Mercedes
AU  - Osuna-Sánchez, Julio
AU  - Ruiz-Moreno, M Isabel
AU  - Bernal-López, M Rosa
AU  - López-Carmona, María D.
AU  - Jiménez-Navarro, Manuel
AU  - Gómez-Doblas, Juan J.
AU  - Lara, José P.
AU  - Gómez-Huelgas, Ricardo
PY  - 2021
DO  - 10.3390/jcm10163540
UR  - http://hdl.handle.net/20.500.12105/18433
AB  - There is little evidence on the use of sodium-glucose cotransporter 2 inhibitors in hospitalised patients. This work aims to analyse the glycaemic and clinical efficacy and safety of empagliflozin continuation in patients with type 2 diabetes...
LA  - eng
PB  - Multidisciplinary Digital Publishing Institute (MDPI)
KW  - Type 2 diabetes
KW  - Heart failure
KW  - Empagliflozin
KW  - Hospitalization
KW  - Diabetes mellitus tipo 2
KW  - Insuficiencia cardíaca
KW  - Hospitalización
KW  - Inhibidores del cotransportador de sodio-glucosa 2
KW  - Humans
KW  - Sodium-Glucose Transporter 2
KW  - Diabetes Mellitus, Type 2
KW  - Blood Glucose
KW  - Hospital Mortality
KW  - Heart Failure
KW  - Diuretics
KW  - Hospitals
KW  - Insulins
KW  - Visual Analog Scale
KW  - Length of Stay
KW  - Treatment Outcome
TI  - Efficacy and Safety of Empagliflozin Continuation in Patients with Type 2 Diabetes Hospitalised for Acute Decompensated Heart Failure
TY  - research article
ER  -